Safe and appropriate use of insulin and other antihyperglycemic agents in hospital

Canadian Journal of Diabetes

Volumn 38, Issue 2, 2014, Pages 94-100

  Cornish, William ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Antihyperglycemic agents; Drug safety; Hypoglycemia; Inpatient diabetes management; Insulin; Medication errors

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOCORTICOID; GLUCOSE; INCRETIN; INSULIN; LINAGLIPTIN; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA; GLUCOSE BLOOD LEVEL;

CLINICAL PRACTICE; DIABETES MELLITUS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL CARE; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LACTIC ACIDOSIS; MEDICAL EDUCATION; MEDICATION ERROR; PANCREATITIS; REVIEW; RISK FACTOR; TREATMENT OUTCOME; CANADA; CHEMICALLY INDUCED; CLINICAL PROTOCOL; CONTRAINDICATIONS; DRUG EFFECTS; EPIDEMIOLOGY; HOSPITAL ORGANIZATION; HOSPITAL PATIENT; PHYSIOLOGIC MONITORING; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PROCEDURES; STANDARDS; TOTAL QUALITY MANAGEMENT;

BLOOD GLUCOSE; CANADA; CLINICAL PROTOCOLS; DIABETES MELLITUS; GUIDELINE ADHERENCE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; MEDICATION ERRORS; MEDICATION SYSTEMS, HOSPITAL; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT;

EID: 84896912435     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.01.002     Document Type: Review

References (30)

1. In-hospital management of diabetes. Can J Diabetes 2013, 37:S77-S81. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
2. Inzucchi S.E. Management of hyperglycemia in the hospital setting. New Engl J Med 2006, 355:1903-1911.
3. Umpierrez G.E., Hellman R., Korytkowski M.T., et al. Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2012, 97:16-38.
4. Pharmacological management of type 2 diabetes. Can J Diabetes 2013, 37:S61-S68. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
5. Lipska K.J., Bailey C.J., Inzucchi S.E. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2011, 34:1431-1437.
6. Rossi A.P., Wellins C.A., Savic M., et al. Use of computer alerts to prevent the inappropriate use of metformin in an inpatient setting. QManage Health Care 2012, 21:235-239.
7. Treatment of diabetes in people with heart failure. Can J Diabetes 2013, 37:S126-S128. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
8. Deusenberry C.M., Coley K.C., Korytkowski M.T., et al. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy 2012, 32:613-617.
9. Varghese P., Gleason V., Sorokin R., et al. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. JHosp Med 2007, 2:234-240.
10. Kelly J.L. Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist. Am J Health-Syst Pharm 2010, 67(Suppl 8):S9-16.
11. Tirkkonen T., Heikkila P., Huupponen R., et al. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. JIntern Med 2010, 268:359-366.
12. Hypoglycemia. Can J Diabetes 2013, 37:S69-S71. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
13. Umpierrez G.E., Korytkowski M. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?. Diabetes Care 2013, 36:2012-2017.
14. Byetta® Product Monograph. Bristol-Myers Squibb Canada, July 31, 2013. Accessed December 9, 2013. http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=84685%26lang=eng.
15. Singh S., Chang H.Y., Richards T.M., et al. Glucagon-like peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med 2013, 173:534-539.
16. Accreditation Canada. High Alert Medications, supplement to the 2013 ROP Handbook: Changes to the Medication Reconciliation and Medication Use ROPs for 2014, pp 19-20. Accessed December 9, 2013. http://www.accreditation.ca/uploadedFiles/News_and_Publications/Publications/ROP_Handbook/SupplementROP-06-2013_en.pdf.
17. Amori R.E., Pittas A.G., Siegel R.D., et al. Inpatient medical errors involving glucose-lowering medications and their impact on patients: Review of 2,598 incidents from a voluntary electronic error-reporting database. Endocr Pract 2008, 14:535-542.
18. Hellman R. Patient safety and inpatient glycemic control: translating concepts into action. Endocr Pract 2006, 12(Suppl 3):49-55.
19. Smith W.D., Winterstein A.G., Johns T., et al. Causes of hyperglycemia and hypoglycemia in adult patients. Am J Health-Syst Pharm 2005, 62:714-719.
20. American Society of Health-System Pharmacists and the Hospital and Health-System Association of Pennsylvania. Recommendations for safe use of insulin in hospitals. October 2004. Accessed December 9, 2013. http://www.ashp.org/s_ashp/docs/files/Safe_Use_of_Insulin.pdf.
21. Cohen M.R. Pharmacists' role in ensuring safe and effective hospital use of insulin. Am J Health-Syst Pharm 2010, 67(Suppl 8):S17-S21.
22. Cobaugh D.J., Maynard G., Cooper L., et al. Enhancing insulin-use safety in hospitals: practical recommendations from an ASHP Foundation expert consensus panel. Am J Health-Syst Pharm 2013, 70:e18-e27.
23. Munt R., Hutton A. Thye 1 diabetes mellitus (T1DM) self-management in hospital: is it possible? A literature review. Contemp Nurse 2012, 40:179-193.
24. Cook C.B., Beer K.A., Seifert K.M., et al. Transitioning insulin pump therapy from the outpatient setting: a review of 6 years' experience with 253 cases. JDiabetes Sci Technol 2012, 6:995-1002.
25. Rubin D.J., Rybin D., Doros G., et al. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care 2011, 34:1723-1728.
26. Baldwin D., Zander J., Munoz C., et al. Arandomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care 2012, 35:1970-1974.
27. Draznin B., Gilden J., Golden S.H., et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013, 36:1807-1814.
28. Korytkowski M., DiNardo M., Donihi A.C., et al. Evolution of a diabetes inpatient safety committee. Endocr Pract 2006, 12(Suppl 3):91-99.
29. Pietras S.M., Hanrahan P., Lindsay M.A., et al. State-of-the-art inpatient diabetes care: the evolution of an academic hospital. Endocr Pract 2010, 16:512-521.
30. ISMP Canada. Knowledge Translation of Insulin Use Interventions / Safeguards. Accessed December 9, 2013. http://www.ismp-canada.org/insulin/.